Max Wagner

Max is a Rask writer/analyst based in Queensland. He covers Australian Exchange-Traded Funds (ETFs), managed funds and personal finance for Rask Media, Best ETFs Australia and our premium membership service, Rask ETFs. Max holds a Bachelor of Business (Finance, International Business) from QUT. Max is passionate about financial education and believes that everybody should learn how to invest and manage their money from a young age.

Max Wagner's latest insights

labor-party-election-wave-bye-goodbye-see-you-later-bags-packed
Dividend Shares

Time To Ditch Bank Shares For This ASX ETF?

There are plenty of exchange-traded funds (ETFs) focused on the large end of the ASX, but are you better off in the iShares S&P/ASX Small Ordinaries ETF (ASX: ISO)?

ASX shares down
Today's ASX news

Clinuvel (CUV) Shares Give Back Returns

The Clinuvel Pharmaceuticals Limited (ASX:CUV) share price was trading 5% lower today. Over the past month, shares of Clinuvel Pharmaceuticals Limited are down 5%.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Skip to content